Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].

What problem does this paper attempt to address?

Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B11 (2021) 420–433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Erratum: Author correction to "The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304].

Geni Ye,Maohua Huang,Yong Li,Jie Ouyang,Minfeng Chen,Qing Weng,Xiaobo Li,Huhu Zeng,Pei Long,Zepei Fan,Junqiang Yin,Wencai Ye,Dongmei Zhang

DOI: https://doi.org/10.1016/j.apsb.2022.12.020

2023-01-01

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.08.015.].
Erratum: Author correction to 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 (2022) 1740-1760].

Minyang Fu,Dandan Peng,Tianxia Lan,Yuquan Wei,Xiawei Wei

DOI: https://doi.org/10.1016/j.apsb.2022.09.013

2022-01-01

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.01.007.].
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Xuan Yang,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mengting Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B (2022) 12 (10) 3934–3951]

Xuan Ye,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mingrui Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Bo Xiao,Yuqi Liang,Ga Liu,Lingshuang Wang,Zhan Zhang,Libin Qiu,Haiting Xu,Sean Carr,Xiaoxiao Shi,Rui L Reis,Subhas C Kundu,Zhenhua Zhu

DOI: https://doi.org/10.1016/j.apsb.2024.06.005

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2024.02.008.].
Erratum to "DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway".

Liang Sun,Yizhou Yao,Ting Lu,Zengfu Shang,Shenghua Zhan,Weiqiang Shi,Guofeng Pan,Xinguo Zhu,Songbing He

DOI: https://doi.org/10.1155/2020/7419534

IF: 2

2020-01-01

Gastroenterology Research and Practice

Abstract:[This corrects the article DOI: 10.1155/2018/2968252.].
Correction: Corrigendum: Overexpression of Mirna-497 Inhibits Tumor Angiogenesis by Targeting VEGFR2

Tu, Yingfeng,Liu, Li,Zhao, Dongliang,Liu, Youbin,Ma, Xiaowei,Fan, Yuhua,Wan, Lin,Huang, Tao,Cheng, Zhen,Shen, Baozhong

DOI: https://doi.org/10.1038/srep21221

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 5: Article number: 13827; published online: 08 September 2015; updated: 16 February 2016. In this Article, Figure 4 is incorrect. The correct Figure 4 appears below as Figure 1.
Erratum to "Protein Z modulates the metastasis of lung adenocarcinoma cells"

Jin Peng,Kai-Ying Yang,Huan Li,Shan-Shan Zheng,Xue-Yi Pan

DOI: https://doi.org/10.1515/biol-2022-0715

2023-08-16

Abstract:[This corrects the article DOI: 10.1515/biol-2022-0667.].
Author correction to ‘Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects’ [Acta Pharmaceutica Sinica B 13 (2023) 2138–2151]

Wei Wei,Qingxuan Zeng,Yan Wang,Xixi Guo,Tianyun Fan,Yinghong Li,Hongbin Deng,Liping Zhao,Xintong Zhang,Yonghua Liu,Yulong Shi,Jingyang Zhu,Xican Ma,Yanxiang Wang,Jiandong Jiang,Danqing Song

DOI: https://doi.org/10.1016/j.apsb.2023.12.014

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.12.009.].
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Author correction to ‘Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers’ [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Tingting Jiang,Guan Wang,Yao Liu,Lu Feng,Meng Wang,Jie Liu,Yi Chen,Liang Ouyang

DOI: https://doi.org/10.1016/j.apsb.2022.02.028

IF: 14.903

2022-03-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.05.004.].

pharmacology & pharmacy
Author Correction to ‘mevalonate Improves Anti-Pd-1/pd-l1 Efficacy by Stabilizing CD274 Mrna’ [acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Wenxin Zhang,Xiaohui Pan,Yanjun Xu,Hongjie Guo,Mingming Zheng,Xi Chen,Honghai Wu,Fengming Luan,Qiaojun He,Ling Ding,Bo Yang

DOI: https://doi.org/10.1016/j.apsb.2023.07.023

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2023.04.002.].
Erratum to ‘B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation’ (JHEP Reports 5 [2023] 100903)

Yao Tang,Zhijie Xu,Fuyuan Xu,Juan Ye,Jianxu Chen,Jianzhong He,Yingchun Chen,Chunhui Qi,Hongbin Huang,Ruiyang Liu,Hong Shan,Fei Xiao

DOI: https://doi.org/10.1016/j.jhepr.2024.101042

IF: 9.917

2024-01-01

JHEP Reports

Abstract:[This corrects the article DOI: 10.1016/j.jhepr.2023.100903.].
Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Wendong Yang,Zhongwei Li,Rong Qin,Xiaorui Wang,Huihui An,Yule Wang,Yan Zhu,Yantao Liu,Shijiao Cai,Shuang Chen,Tao Sun,Jing Meng,Cheng Yang

DOI: https://doi.org/10.3389/fonc.2021.828861

IF: 4.7

2022-01-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01187.].

oncology
Author Correction to “TMEM16A Inhibits Angiotensin II-induced Basilar Artery Smooth Muscle Cell Migration in a WNK1-dependent Manner” [acta Pharm Sin B 11(12) (2021) 3994–4007]

Huaqing Zheng,Xiaolong Li,Xin Zeng,Chengcui Huang,Mingming Ma,Xiaofei Lv,Yajuan Zhang,Lu Sun,Guanlei Wang,Yanhua Du,Yongyuan Guan

DOI: https://doi.org/10.1016/j.apsb.2023.01.001

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.04.013.].
Correction: Cui, H., et al. BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation. Int. J. Mol. Sci. 2019, 20, 4062

Herong Cui,Wenbo Guo,Beibei Zhang,Guoping Li,Tong Li,Yanyan Yuan,Na Zhang,Yuwei Yang,Wuwen Feng,Fuhao Chu,Shenglan Wang,Bing Xu,Penglong Wang,Haimin Lei

DOI: https://doi.org/10.3390/ijms21186814

IF: 5.6

2020-09-17

International Journal of Molecular Sciences

Abstract:The authors wish to make the following corrections to this paper [...]

biochemistry & molecular biology,chemistry, multidisciplinary

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B11 (2021) 420–433]

Erratum: Author correction to "The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304].

Erratum: Author correction to 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 (2022) 1740-1760].

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B (2022) 12 (10) 3934–3951]

Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Erratum to "DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway".

Correction: Corrigendum: Overexpression of Mirna-497 Inhibits Tumor Angiogenesis by Targeting VEGFR2

Erratum to "Protein Z modulates the metastasis of lung adenocarcinoma cells"

Author correction to ‘Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects’ [Acta Pharmaceutica Sinica B 13 (2023) 2138–2151]

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Author correction to ‘Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers’ [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Author Correction to ‘mevalonate Improves Anti-Pd-1/pd-l1 Efficacy by Stabilizing CD274 Mrna’ [acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Erratum to ‘B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation’ (JHEP Reports 5 [2023] 100903)

Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Author Correction to “TMEM16A Inhibits Angiotensin II-induced Basilar Artery Smooth Muscle Cell Migration in a WNK1-dependent Manner” [acta Pharm Sin B 11(12) (2021) 3994–4007]

Correction: Cui, H., et al. BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation. Int. J. Mol. Sci. 2019, 20, 4062